Innovassynth Technologies (533315)
TurnaroundScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹25 |
| Market Cap | ₹69.96 Cr |
| P/E Ratio | 0 |
| ROCE | -9.18% |
| ROE | -19.83% |
| Dividend Yield | 0% |
| Profit Growth | 17.31% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹50.1 — ₹98.5 |
| Sector | Finance |
| Book Value | ₹6.86 |
Strengths
- Small market cap of ₹70 crore offers potential for outsized returns if assets are monetized
- Piotroski F-Score of 5/9 indicates moderate financial health despite losses
- Profit growth figure of 17.31% suggests improving year-over-year, albeit from a low or negative base
- Listed on NSE/BSE providing visibility and exit liquidity for investors
Concerns
- Zero sales revenue and latest quarter net loss of ₹5 crore show no active earnings engine
- Negative ROE of -19.83% and ROCE of -9.18% are destroying shareholder value
- Trading at P/B of 3.64, a steep premium to book value of ₹6.86, with no earnings to justify it
- Price of ₹25 is below the 52-week low of ₹50.10, a sign of severe negative momentum
AI Analysis
When I look at Innovassynth Technologies, I see a company that fails the first test I demand of any investment: it must be a business I can understand and that earns a decent return on tangible capital. Here we have an investment company with no sales, a latest quarter net loss of ₹5 crore, and a return on equity of negative 19.83%. That means every rupee of book value is being eroded, not compounded. The book value is just ₹6.86 per share, yet the market is asking ₹25 — over three and a half times book. For that premium, I should be getting a wonderful business, not one that is burning cash and has no identifiable moat. The so-called profit growth of 17.31% is meaningless when the base is negative and the latest quarter is still loss-making. The Piotroski F-score of 5 out of 9 suggests some financial stability, but that is hardly a reason to commit capital. Also, the price has fallen below the lower end of its 52-week range — from a low of ₹50.10 down to ₹25 — which tells me the market is repricing negative expectations. In Graham's terms, this is not a margin of safety; it is a margin of hope. As value investors, we must avoid cigar-butt investments where the only apparent asset is the possibility of a turnaround. Without clarity on the underlying investments, their realizable value, or any plan to unlock shareholder value, this remains a speculative vehicle. I would rather watch from the sidelines than lose money on a company whose only number that matters is a negative ROE and a shrinking book. Patience is my friend, but this is not a friend I wish to own.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer